Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema
NCT01306513
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Emphysema
Interventions
BIOLOGICAL:
autologous bone marrow derived mesenchymal stromal cells
Sponsor
Leiden University Medical Center